402 related articles for article (PubMed ID: 14624398)
21. Effects of non-esterified fatty acid availability on insulin stimulated glucose utilisation and tissue pyruvate dehydrogenase activity in the rat.
Kruszynska YT; McCormack JG; McIntyre N
Diabetologia; 1990 Jul; 33(7):396-402. PubMed ID: 2119322
[TBL] [Abstract][Full Text] [Related]
22. The effect of 3-mercaptopicolinic acid and substrate interactions on the incorporation of lipogenic precursors into glyceride-glycerol, glyceride-fatty acids and nonesterified fatty acids in bovine adipose tissue.
Smith SB; Prior RL
Biochim Biophys Acta; 1982 Aug; 712(2):365-73. PubMed ID: 7126610
[TBL] [Abstract][Full Text] [Related]
23. Effect of captopril, losartan, and bradykinin on early steps of insulin action.
Carvalho CR; Thirone AC; Gontijo JA; Velloso LA; Saad MJ
Diabetes; 1997 Dec; 46(12):1950-7. PubMed ID: 9392479
[TBL] [Abstract][Full Text] [Related]
24. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
Magnan C; Gilbert M; Kahn BB
Lipids; 1996 Nov; 31(11):1141-9. PubMed ID: 8934446
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M
Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040
[TBL] [Abstract][Full Text] [Related]
26. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
27. Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.
Stumvoll M; Jacob S; Wahl HG; Hauer B; Löblein K; Grauer P; Becker R; Nielsen M; Renn W; Häring H
J Clin Endocrinol Metab; 2000 Oct; 85(10):3740-5. PubMed ID: 11061533
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
[TBL] [Abstract][Full Text] [Related]
29. Role of fatty acid synthesis in the control of insulin-stimulated glucose utilization by rat adipocytes.
Fried SK; Lavau M; Pi-Sunyer FX
J Lipid Res; 1981 Jul; 22(5):753-62. PubMed ID: 7026709
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone-induced insulin resistance and its relationship to lipid availability in the rat.
Hettiarachchi M; Watkinson A; Jenkins AB; Theos V; Ho KK; Kraegen EW
Diabetes; 1996 Apr; 45(4):415-21. PubMed ID: 8603761
[TBL] [Abstract][Full Text] [Related]
31. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion.
Cettour-Rose P; Theander-Carrillo C; Asensio C; Klein M; Visser TJ; Burger AG; Meier CA; Rohner-Jeanrenaud F
Diabetologia; 2005 Apr; 48(4):624-33. PubMed ID: 15756538
[TBL] [Abstract][Full Text] [Related]
32. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Koopmans SJ; Kushwaha RS; DeFronzo RA
Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
[TBL] [Abstract][Full Text] [Related]
33. Effects of new hypoglycemic agent A-4166 on lipolysis and lipogenesis in rat adipocytes.
Macho L; Fickova M; Zorad S; Sebokova E; Klimes I
Endocr Regul; 2000 Sep; 34(3):119-26. PubMed ID: 11074662
[TBL] [Abstract][Full Text] [Related]
34. Leptin increases glucose transport and utilization in skeletal muscle in vitro.
Ceddia RB; William WN; Curi R
Gen Pharmacol; 1998 Nov; 31(5):799-801. PubMed ID: 9809481
[TBL] [Abstract][Full Text] [Related]
35. A novel insulin sensitizer (S15511) enhances insulin-stimulated glucose uptake in rat skeletal muscles.
Jessen N; Selmer Buhl E; Pold R; Schmitz O; Lund S
Horm Metab Res; 2008 Apr; 40(4):269-75. PubMed ID: 18548386
[TBL] [Abstract][Full Text] [Related]
36. Acute peripheral tissue effects of ghrelin on interstitial levels of glucose, glycerol, and lactate: a microdialysis study in healthy human subjects.
Vestergaard ET; Møller N; Jørgensen JO
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1273-80. PubMed ID: 23592479
[TBL] [Abstract][Full Text] [Related]
37. Age-related changes in fatty acid composition in muscles.
Chvojková S; Kazdová L; Divisová J
Tohoku J Exp Med; 2001 Oct; 195(2):115-23. PubMed ID: 11846207
[TBL] [Abstract][Full Text] [Related]
38. Regulation of gene expression for lipogenic enzymes in the liver and adipose tissue of hereditary hypertriglyceridemic, insulin-resistant rats: effect of dietary sucrose and marine fish oil.
Seböková E; Klimes I; Gasperíková D; Bohov P; Langer P; Lavau M; Clandinin MT
Biochim Biophys Acta; 1996 Sep; 1303(1):56-62. PubMed ID: 8816853
[TBL] [Abstract][Full Text] [Related]
39. Effects of plane of nutrition and 2,4-thiazolidinedione on insulin responses and adipose tissue gene expression in dairy cattle during late gestation.
Schoenberg KM; Overton TR
J Dairy Sci; 2011 Dec; 94(12):6021-35. PubMed ID: 22118090
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar.
Hegarty BD; Furler SM; Oakes ND; Kraegen EW; Cooney GJ
Endocrinology; 2004 Jul; 145(7):3158-64. PubMed ID: 15059948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]